Abstract:OBJECTIVE:To explore the impact of hydrogen sulfide (H2S) donor, sodium hydrosulfide (NaHS), on pulmonary vascular structure and vasoactive peptides in rats with pulmonary hypertension induced by high pulmonary blood flow.METHODS:Thirty-two male Wistar rats, weighing 120-140 g, were randomly divided into shunt group (n=8), shunt + NaHS group (n=8), sham group (n=8), and sham + NaHS group (n=8). Rats in shunt group and shunt + NaHS group were subjected to an abdominal aorta-inferior vena cava shunt to create an animal model of high pulmonary flow. In the sham group and sham + NaHS group, rats experienced the same experimental processes except the shunting procedure. Rats in shunt + NaHS group and sham + NaHS group were intraperitoneally injected with an exogenous H2S donor--NaHS, at a dose of 56 micromol/(kg x d). Meanwhile, rats in shunt group and sham group were injected with the same volume of physiological saline. After 11 weeks of experiment, systolic pulmonary artery pressure (SPAP) of each rat was evaluated by using a right cardiac catheterization procedure. Heart tissues were separated as right ventricular (RV) and left ventricular plus septum (LV + SP), and the ratio of RV to LV + SP [RV/(LV + SP)] was calculated. The morphologic changes including micro-and ultra-structural changes of pulmonary arteries of rats were observed under optical microscope and electro-microscope, respectively. The percentage of muscular artery (MA) in small pulmonary arteries was calculated. The change of relative medial thickness (RMT) of pulmonary arteries was examined. H2S concentration in plasma was evaluated by modified sulfide electrode method. Endothelin-1 (ET-1), atrial natriuretic peptide (ANP), calcitonin gene related peptide (CGRP), and proadrenomedullin peptide (PAMP) were calculated by radioimmunoassay kit.RESULTS:After 11 weeks of shunt, compared with sham group, SPAP increased by 48.63% (P < 0.01 ) and RV/ (LV + SP) increased by 21.95% (P < 0.01). Plasma H2S decreased significantly (P < 0.01). The percentage of MA increased significantly (P < 0.01); RMT increased significantly (P < 0.01). The changes of ultra-structure of pulmonary arteries showed that endothelial cells became swollen and desquamation, internal elastic lamina became irregular, and smooth muscular cells increased in size, showing synthetic phenotype. After the rats with shunt was administered with NaHS for 11 weeks, plasma H2S increased significantly (P < 0.01). SPAP decreased by 19.82% and RV/(LV + SP) decreased by 7.31% (P < 0.01). The percentage of MA decreased significantly and RMT decreased significantly (P < 0.01). The changes of ultra-structure of the pulmonary arteries showed lighten significantly. Plasma ET-1, ANP, and CGRP decreased significantly (all P < 0.01), whereas PAMP increased significantly than that of shunt group (P < 0.01).CONCLUSION:The reduced production of endogenous H2S is one of mechanism of pulmonary hypertension and pulmonary vascular structure remodeling in rats with high pulmonary blood flow. H2S plays an important regulatory effect on vasoactive peptide ET-1,+ ANP, CGRP and PAMP.

Role of vascular mediators in the pathogenesis of hepatopulmonary syndrome in rats

Changes of serum cytokines and pulmonary intravascular macrophages in rats with hepatopulmonary syndrome

Progress in investigating the pathogenesis of hepatopulmonary syndrome.

Study on the relationship between pathological changes of lung and hypoxemia in cirrhotic rats

[Expression of ET-1 Mrna in the Lung of Hepatopulmonary Syndrome Rats].

[Lung Expression of Tissue Factor Mrna and Its Significance in a Rat Model of Hepatopulmonary Syndrome].

Hepatopulmonary Syndrome: the Role of Intra-Abdominal Hypertension and A Novel Mouse Model

Expressions of NOS and NOS Mrna in the Lung of Rats with Hepatopulmonary Syndrome

Pathophysiological basis of hepatopulmonary syndrome

M2 macrophage accumulation contributes to pulmonary fibrosis, vascular dilatation, and hypoxemia in rat hepatopulmonary syndrome

[Significance of Lipopolysaccharides, Toll-Like Receptor and Inducible Nitric Oxide Synthase in Hepatopulmonary Syndrome].

The pulmonary manifestation of hepatopulmonary syndrome presented by CT and DSA based on pathologic changes

Spleen derived monocytes regulate pulmonary vascular permeability in Hepatopulmonary syndrome through the OSM-FGF/FGFR1 signaling

Role of Heme Oxygenase-1/Carbon Monoxide in Lung Injury Induced by Hepatic Ischemia-Reperfusion in the Rats with Hyperdynamic Circulation

Impact of Hydrogen Sulfide Donor on Pulmonary Vascular Structure and Vasoactive Peptides in Rats with Pulmonary Hypertension Induced by High Pulmonary Blood Flow

Role of Serine Threonine Protein Kinase-1 and Smad3 in Lung Tissues in Development of Hepatopulmonary Syndrome in Rats

Multiple Pathogenic Factor-Induced Complications of Cirrhosis in Rats: A New Model of Hepatopulmonary Syndrome with Intestinal Endotoxemia

The association of lipopolysaccharide and inflammatory factors with hepatopulmonary syndrome and their changes after orthotopic liver transplantation.

The Regulatory Effect of Endogenous Hydrogen Sulfide on Pulmonary Vascular Structure and Gasotransmitters in Rats with High Pulmonary Blood Flow.

Alteration of pulmonary vascular structure and gaseous molecules in rats with pulmonary hypertension induced by high pulmonary blood flow

Sodium Hydrosulfide Alleviated Pulmonary Vascular Structural Remodeling Induced by High Pulmonary Blood Flow in Rats